Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Niox Group PLC

NIOX.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Pharmaceuticals ·

UK Small Cap Analyst: BUY

Last Close

$0.91

▲ +2.42%

Market Cap $383.66M · Vol 978.32K

Key Metrics

P/E Ratio

41.12

FWD: 19.79

Market Cap

$383.66M

Small Cap

Div Yield

2.29%

Annual dividend

EPS Growth

+3.79%

YoY

RSI (14)

59.74

Momentum

Beta

-0.13

vs Market

52W High

$1.05

12.71% below

52W Low

$0.73

28.09% above

Volume

978.32K

Avg 829.12K

P/B

3.77

Price-to-book

ROE

18.66%

Return on equity

Free Float

79.07%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Niox Group PLC (NIOX.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NIOX.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.68%

+15.36%

+10.46%

+6.62%

YTD

+1.81%

+0.90%

+8.79%

+74.78%

Financials & Valuation

TTM · Annual

Total Revenue	$65.61M
Net Income	$9.43M
Revenue Growth (YoY)	+12.98%
Gross Margin	69.82%
Operating Margin	22.59%
Net Profit Margin	14.37%
ROE	18.66%
ROA · ROIC	15.49% · 11.00%

P/E Ratio	41.12
Forward P/E (FY1)	19.79
PEG Ratio	0.35
P/S	5.81
P/B	3.77
P/FCF	19.79
EPS Growth	+3.79%
Outstanding Shares	420.87M

Technical Indicators

50-Day SMA	$0.81
200-Day SMA	$0.86
RSI (14)	59.74
Beta	-0.13
52-Week High	$1.05
52-Week Low	$0.73

Volume Today	978.32K
Avg Daily Volume (30D)	829.12K
Relative Volume	1.18x
Volatility (10D)	22.55
Volatility (30D)	27.79
Free Float	79.07%

Analyst Consensus

BUY

Current Price $0.91

Mean Target $1.09

52W Low$0.73 52W High$1.05

Current

Target

$0.73 $1.05

Current Analyst target

+19.22% upside potential · 5 analysts

Identifiers

ExchangeLSE

FIGIBBG005ZCRJ84

ISINGB00BJVD3B28

CountryUnited Kingdom

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

NIOX Group plc is a United Kingdom-based diagnostics and management company. The Company is engaged in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNO), a precise biomarker for asthma. The Company's NIOX VERO is also the device of choice by clinical research organizations for respiratory studies. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company provides products and services via its direct sales organization and extensive distributor network in over 50 countries.